🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Shengliang Zhang

Brown University

ORCID: 0000-0001-6368-1147

Also affiliated with City University of Hong Kong, Shenzhen Research Institute, Energy Storage Systems (United States), Zhejiang University, Nanjing University of Aeronautics and Astronautics

MedicineBiochemistry, Genetics and Molecular BiologyMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells”.

Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.02.230839
N/A
0DataRank · unranked
14 citations

Kelsey E. Huntington, Shengliang Zhang, Lindsey Carlsen, Eui‐Young So, Cassandra Parker +16 more

P53-independent restoration of p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.20.347401
N/A
0DataRank · unranked
3 citations

Nagib Ahsan, Amriti R. Lulla, Avital Lev, Philip H. Abbosh, David T. Dicker +3 more

Targeting the Integrated Stress Response in Cancer Therapy

Frontiers in Pharmacology(2021)10.3389/fphar.2021.747837
N/A
0DataRank · unranked
186 citations

Shengliang Zhang, Lanlan Zhou, Attila A. Seyhan, Liz Hernandez Borrero, Yiqun Zhang +2 more

P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9

Neoplasia(2021)10.1016/j.neo.2021.01.004
N/A
0DataRank · unranked
28 citations

Nagib Ahsan, Amriti R. Lulla, Avital Lev, Philip H. Abbosh, David T. Dicker +3 more

Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma

Frontiers in Pharmacology(2021)10.3389/fphar.2021.751568
N/A
0DataRank · unranked
18 citations

Nicholas R. Liguori, Lindsey Carlsen, Cassandra Parker, Liz Hernandez Borrero, Shengliang Zhang +6 more

Small-Molecule NSC59984 Induces Mutant p53 Degradation through a ROS-ERK2-MDM2 Axis in Cancer Cells

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-0149
N/A
0DataRank · unranked
23 citations

Lanlan Zhou, Wafik S. El-Deiry, Shengliang Zhang

Neuroendocrine differentiation (ND) in sensitivity of neuroendocrine tumor (NET) cells to ONC201/TIC10 cancer therapeutic

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.08.28.610183
N/A
0DataRank · unranked
2 citations

Maximilian Pinho-Schwermann, Shengliang Zhang, Connor Purcell, Wafik S. El‐Deiry, Elizabeth Ding

Tumor suppressor p73 transcriptionally regulates c-FLIP to impede its priming of extrinsic apoptosis while a “switcher compound” degrades c-FLIP protein

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.21.590479
N/A
0DataRank · unranked
0 citations

Lanlan Zhou, Wafik S. El‐Deiry, Shengliang Zhang